Artificial intelligence company UNITH (ASX: UNT) has officially confirmed the launch date for interFace, its innovative self-service Digital Human platform. Slated for release on 23 September 2024, interFace is a self-service offering that enables businesses to generate and deploy digital humans on their own, that can work 24/7 and converse in multiple languages, powered by
Read More
After months of uncertainty having struggled with solvency and a $6 million fine from the ACCC, Australia’s largest online book retailer Booktopia (ASX: BKG) has been sold by administrators in a move that will manage the financially distressed company, but see shareholders returned nothing. The sale was finalised on Friday, 16 August by administrators from
Read More
The Centers for Medicare & Medicaid Services has approved a new Healthcare Common Procedure Coding System code for the NeuroNode, patent technology by Control Bionics (ASX: CBL). This approval, effective from 1 October 2024, introduces a reimbursement rate of US$4,300 for the NeuroNode, a significant enhancement from the previous reimbursement conditions. Control Bionics is a
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read More
As Australia battles economic uncertainty which has seen a major pullback in household spending, mortgages stress is pushing many families to breaking point with a bumper result for property tech company Domain Holdings (ASX: DHG) which has seen more listings at a time when borrowing power is weakened due to high interest rates. For the
Read More
Cost-of-living pressures and the inflationary pressure on raw materials is having an impact on childcare operator Nido Education (ASX: NDO) which has forewarned that it is unlikely to meet the profit expectations for 2024 that were outlined in their IPO Prospectus when listing on the ASX in October 2023. The childcare centre operator has cited
Read More
Firebrick Pharma (ASX: FRE) is making waves with its Nasodine Nasal Spray disinfectant, having recently executed an amended licence and distribution agreement to bring the product to the Philippines. The amended agreement with S.V. More Pharma Corporation (SV More) allows for the local manufacture of Nasodine, shifting from its previous importation from Australia. This strategic
Read More
Australian health company, Wellnex Life (ASX: WNX) has secured a pivotal partnership and received its first purchase order from global provider Haleon to supply Paracetamol Soft Gel Liquid Analgesic to the UK market. In today’s health-conscious world where consumers demand innovative and effective solutions, Wellnex Life’s partnership with Haleon positions the Company at the forefront
Read More
When James Warburton handed over the reins of Seven West Media (ASX: SWM) to Jeff Howard in April 2024, it was always going to be a baptism by fire with the media giant grappling with formidable challenges in an increasingly difficult television landscape. This was reflected with the Company reporting a significant downturn in earnings,
Read More
Bio-Gene Technology Limited (ASX: BGT), an Australian innovator in bio-insecticides, has entered into a strategic collaboration with Envu, a global provider of environmental solutions to evaluate its flagship product Flavocide for use in public and private sector mosquito management. Over half of the global population is at risk from vector-borne diseases like malaria, Zika virus,
Read More
